Shopping Cart
Remove All
Your shopping cart is currently empty
Kifunensine, an alkaloid discovered in Kitasatosporia kifunense, functions as a glycosylation pathway inhibitor and immunomodulator. It strongly inhibits α-mannosidase I in the Golgi apparatus and may be utilised in studies of endoplasmic reticulum stress.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 50 mg | $2,400 | 8-10 weeks | 8-10 weeks |
| Description | Kifunensine, an alkaloid discovered in Kitasatosporia kifunense, functions as a glycosylation pathway inhibitor and immunomodulator. It strongly inhibits α-mannosidase I in the Golgi apparatus and may be utilised in studies of endoplasmic reticulum stress. |
| In vitro | Methods: SK-N-SH cells were pretreated with kifunensine (1 μg/ml) for 72 hours to examine the effects of ERAD inhibition on UPR and ER stress. Results: Kifunensine decreased UPR activation and ER stress toxicity by inhibiting ERAD, and altered lysosomal morphology and distribution.[3] |
| In vivo | Methods: Kifunensine (250 μg, administered for 3 consecutive days) was intraperitoneally injected into C57BL/6 mice to investigate the role of MHCII glycosylation in carbohydrate antigen-specific immune responses of Parazacco spilurus subsp. spilurus. Results: Kifunensine treatment significantly reduced PSA-driven immune response, which could be restored by adoptive transfer of normally glycosylated APCs. [4] |
| Synonyms | LY231514 disodium heptahydrate |
| Molecular Weight | 232.19 |
| Formula | C8H12N2O6 |
| Cas No. | 109944-15-2 |
| Smiles | [H][C@]12NC(=O)C(=O)N1[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O |
| Relative Density. | 1.85 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| Solubility Information | DMSO: 8 mg/mL (34.45 mM), Sonication is recommended. | |||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 0.5 mg/mL (2.15 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.